The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 30, 2018

Filed:

Jan. 28, 2011
Applicants:

Seung Hyun Jung, Goyang-si, KR;

Young Hee Jung, Seoul, KR;

Wha IL Choi, Seoul, KR;

Jung Beom Son, Hwaseong-si, KR;

Eun Ju Jeon, Hwaseong-si, KR;

IN Ho Yang, Yongin-si, KR;

Tae Hun Song, Hwaseong-si, KR;

MI Kyoung Lee, Seoul, KR;

Myoung Sil Ko, Yongin-si, KR;

Young Gil Ahn, Seongnam-si, KR;

Maeng Sup Kim, Seoul, KR;

Young Jin Ham, Seoul, KR;

Tae BO Sim, Seoul, KR;

Hwan Geun Choi, Seoul, KR;

Jung MI Hah, Seoul, KR;

Dong-sik Park, Busan, KR;

Hwan Kim, Goyang-si, KR;

Inventors:

Seung Hyun Jung, Goyang-si, KR;

Young Hee Jung, Seoul, KR;

Wha Il Choi, Seoul, KR;

Jung Beom Son, Hwaseong-si, KR;

Eun Ju Jeon, Hwaseong-si, KR;

In Ho Yang, Yongin-si, KR;

Tae Hun Song, Hwaseong-si, KR;

Mi Kyoung Lee, Seoul, KR;

Myoung Sil Ko, Yongin-si, KR;

Young Gil Ahn, Seongnam-si, KR;

Maeng Sup Kim, Seoul, KR;

Young Jin Ham, Seoul, KR;

Tae Bo Sim, Seoul, KR;

Hwan Geun Choi, Seoul, KR;

Jung Mi Hah, Seoul, KR;

Dong-sik Park, Busan, KR;

Hwan Kim, Goyang-si, KR;

Assignees:

HANMI PHARM. CO., LTD., Hwaseong-si, KR;

HANMI SCIENCE CO., LTD., Hwaseong-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 495/04 (2006.01); A61K 31/519 (2006.01); A61P 35/00 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 19/02 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01);
Abstract

The present invention relates to a novel bicyclic heteroaryl derivative, a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof having an improved inhibitory activity for protein kinases, and a pharmaceutical composition for preventing or treating an abnormal cell growth disorder comprising same as an active ingredient.


Find Patent Forward Citations

Loading…